Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer.
$1.17-1.68%
报价 2026-11-13
市值
$311.4M
EV
$588.1M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -53.9%
$1.17$2.54
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | $311.4M | -1.7% | – | 15.7% | – | – | – | |
| KYTXKyverna Therapeutics, Inc. | $319.3M | +0.4% | +86.6% | 0% | – | – | – | |
| XFORX4 Pharmaceuticals, Inc. | $318.6M | -1.6% | -49.4% | 81.2% | – | – | – | |
| EVMNFunctional Brands, Inc. Common Stock | $315.5M | -4.9% | -76.2% | 100% | – | – | – | |
| BNTCBenitec Biopharma Inc. | $315.4M | -0.6% | -13.8% | 0% | – | – | – | |
| LRMRLarimar Therapeutics, Inc. | $313.7M | +11.9% | – | 0% | – | – | – | |
| AGMBAgomAb Therapeutics N.V. American Depositary Shares | $313.2M | 0.0% | – | 0% | – | – | – | |
| MPLTMapLight Therapeutics, Inc. | $309M | +2.5% | – | 0% | – | – | – | |
| AGENAgenus Inc. | $304.5M | -2.0% | +13.6% | 76.5% | 9.7x | 3.4x | – | |
| 同行中位数 | – | – | -13.8% | 0% | 9.7x | 3.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。